DEFINITIVE PROXY STATEMENT

Company

Theriva Biologics, Inc.

Filed

December 13, 1999

Period of Report

January 20, 2000

Accession Number

0000921895-99-000899

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →